PersonalPath Systems

PersonalPath Systems is a precision medicine company that developed a clinical decision support platform designed to help oncologists identify personalized treatment options for cancer patients. The company's technology integrates genomic data with clinical information to provide actionable insights and facilitate the matching of patients to targeted therapies and clinical trials. Founded by experts in precision oncology, the platform aims to simplify the interpretation of complex molecular profiles for use in clinical practice. In September 2021, PersonalPath Systems was acquired by M2GEN, a health informatics company, to enhance its oncology-focused data and informatics offerings. This acquisition allowed for the integration of PersonalPath's decision support tools into M2GEN's broader oncology network, supporting both clinical care and pharmaceutical research.